Effect of Low Glycemic Index Diet on Body Composition and Mechanism of Obese Women
NCT ID: NCT01255228
Last Updated: 2010-12-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2010-05-31
2011-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study will be a randomized, crossover, controlled clinical trails. The experiment period have six weeks, each participants will provide low GI diet (lunch and dinner). On the 0, 3, 6 week, subjects will measurement their body composition (body weight, body mass, waist and hip circumferences) and collect fasting blood samples to analysis the lipid profile, free fatty acid, blood sugar, insulin, adiponectin, leptin and fatty acid synthesis enzymes. Statistical analysis will be performed by paired t-test. The study expect that long-term low GI diet intervention have beneficial effects on regulate body composition of obese women.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low glycemic index diet
The study expect that long-term low GI diet intervention have beneficial effects on regulate body composition of obese women
Low glycemic index diet
The study expect that long-term low GI diet intervention have beneficial effects on regulate body composition of obese women
diet intervention
The study expect that long-term low GI diet intervention have beneficial effects on regulate body composition of obese women
Low glycemic index diet
The study expect that long-term low GI diet intervention have beneficial effects on regulate body composition of obese women
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Low glycemic index diet
The study expect that long-term low GI diet intervention have beneficial effects on regulate body composition of obese women
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* type 2 diabetes mellitus or impaired glucose tolerance
* serious liver or renal disease, gastro-intestinal disease
* proceed serious diet control for formerly three months
* take any supplemental food products or medications known to influence lipid or carbohydrate metabolism
20 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Taipei Medical University WanFang Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Taipei Medical University, School of Nutrition and Health Sciences
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jen-Fang Liu
Role: PRINCIPAL_INVESTIGATOR
Taipei Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Taipei Medical University
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
99055
Identifier Type: -
Identifier Source: org_study_id